Users Online Now:
1,767
(
Who's On?
)
Visitors Today:
850,314
Pageviews Today:
1,393,637
Threads Today:
548
Posts Today:
8,833
02:35 PM
Directory
Adv. Search
Topics
Forum
Back to Forum
Back to Thread
REPLY TO THREAD
Subject
Pfizer has a new alopecia drug! Will's slap was an ad!
User Name
Font color:
Default
Dark Red
Red
Orange
Brown
Yellow
Green
Olive
Cyan
Blue
Dark Blue
Indigo
Violet
Black
Font:
Default
Verdana
Tahoma
Ms Sans Serif
In accordance with industry accepted best practices we ask that users limit their copy / paste of copyrighted material to the relevant portions of the article you wish to discuss and no more than 50% of the source material, provide a link back to the original article and provide your original comments / criticism in your post with the article.
[quote:pish:MV81MDk2NjM5XzkzNDQyODQxX0IzQkZBMEZE] [quote:Quantum Joker:MV81MDk2NjM5XzkzNDQyMzYxXzhEREMyRDlF] [quote:pish:MV81MDk2NjM5XzkzNDQyMjk0XzdCRUNBRkU5] Carbon nano tubes will self assemble into luxurious hair before your eyes! Covid deaths were worth it to bring you fabulous hair! [/quote] Nano-Medusa Hair! Graphene Oxide snakes wriggling on top of the bald heads! [/quote] And you get full bars of 5G! What’s not to like? You all just jealous of future tech! [/quote]
Original Message
Pfizer has been developing Ritlecitinib, a drug for aloepecia.
[
link to www.fiercebiotech.com (secure)
]
"Pfizer's alopecia therapy has been linked to a reduction in hair loss in early topline clinical data, setting the stage for a scrap with Eli Lilly and Incyte in the title fight for a potential blockbuster opportunity.
Ritlecitinib has met its primary endpoint in a phase 2b/3 clinical trial of patients with alopecia areata, Pfizer reported Wednesday. The update on the JAK3/TEC inhibitor comes months after Eli Lilly and Incyte reported late-phase success in alopecia.
There are currently no FDA-approved treatments for alopecia, an autoimmune disease characterized by hair loss, but multiple drugs could come to market in the indication over the coming years. Pfizer’s ritlecitinib joined Lilly and Incyte’s Olumiant on the list of drugs to hit the primary endpoint in pivotal alopecia trials on Wednesday—and Concert Pharmaceuticals is following closely behind."
More pure PR at source.
Pictures (click to insert)
General
Politics
Bananas
People
Potentially Offensive
Emotions
Big Round Smilies
Aliens and Space
Friendship & Love
Textual
Doom
Misc Small Smilies
Religion
Love
Random
View All Categories
|
Next Page >>